title: Metabolic suppression of platelet-type 12-lipoxygenase in human uterine cervix with invasive carcinoma.
abstract: Several types of lipoxygenases with various functions occur in mammalian cells. Although the presence of 12-lipoxygenase activity has been reported in uterine tissues, neither its type nor its biological functions have yet been established. Moreover, the putative role of uterine 12-lipoxygenase in cervical cancer has not been addressed before. Homogenates of uterine tissues from women without cancer and from patients with invasive cervical carcinoma were incubated with (1-(14)C)-arachidonic acid under various conditions and the labelled reaction products were analyzed both by thin-layer chromatography and by high-pressure liquid chromatography. 12-Lipoxygenase protein was estimated by Western blot using anti-serum against recombinant human platelet-type 12-lipoxygenase. Highest concentrations and activities of 12-lipoxygenase were found in the exocervix. The formation of 12S-hydroxy-5Z,8Z,10E, 14Z-eicosatetraenoic acid (12-HETE) was stimulated by micromolar concentrations of 13S-hydroperoxy-9Z,11E-octadecadienoic acid, suggesting metabolic control of the 12-lipoxygenase activity via the hydroperoxide tone. Immunohistochemical investigation revealed that the enzyme is mainly located in the squamous epithelium, and is of platelet-type. Significantly lower values for the 12-HETE formation were found in samples from patients with invasive cervical carcinoma, whereas the amount of immunochemically detectable 12-lipoxygenase protein was unaltered. At the same time the expression levels of the bcl-2 gene were enhanced. Thus, it is concluded that during carcinogenesis the hydroperoxide-reducing capacity of the uterine cervix tissue is enhanced, possibly mediated by bcl-2 protein, and in turn metabolically suppresses the 12-lipoxygenase activity. Furthermore, the data suggest an anti-carcinogenic action of 12-lipoxygenase in human cervix, in contrast to its reported pro-carcinogenic action in breast cancer.
authors.affiliation: Eicosanoid Research Division, Gynaecology Department, Benjamin Franklin University Medical Centre, Free University Berlin, Berlin, Germany. nigam@zedat.fu-berlin.de
authors.forename: S
authors.initials: S
authors.lastname: Nigam
authors.forename: G S
authors.initials: GS
authors.lastname: Kumar
authors.forename: M
authors.initials: M
authors.lastname: Sutherland
authors.forename: T
authors.initials: T
authors.lastname: Schewe
authors.forename: H
authors.initials: H
authors.lastname: Ikawa
authors.forename: Y
authors.initials: Y
authors.lastname: Yamasaki
authors.forename: N
authors.initials: N
authors.lastname: Ueda
authors.forename: S
authors.initials: S
authors.lastname: Yamamoto
mesh_terms: D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid / Q000378:metabolism; D001092:Arachidonate 12-Lipoxygenase / Q000378:metabolism*; D001792:Blood Platelets / Q000201:enzymology*; D002584:Cervix Uteri / Q000201:enzymology*; D004717:Endometrium / Q000201:enzymology; D005260:Female; D019254:Genes, bcl-2; D006801:Humans; D009215:Myometrium / Q000201:enzymology; D009361:Neoplasm Invasiveness; D013379:Substrate Specificity; D014594:Uterine Neoplasms / Q000201:enzymology* / Q000473:pathology
chemical_list: D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; D001092:Arachidonate 12-Lipoxygenase